Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05257941 · ClinicalTrials.gov registry record · Phase 1
ESP Block VS Intrathecal Opioid After Laparoscopic Colorectal Surgery
A Phase 1 study, sponsored by Indiana University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 116
- Enrollment target
NCT05257941 is a Phase 1 study that was terminated before completion, run by Indiana University. The registered enrollment target is 116 participants.
The verdict
NCT05257941, a Phase 1 study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 116 participants
- Enrollment target
Study Summary
This study is being done to compare 2 types of pain control methods and determine which is more effective postoperatively for laparoscopic colorectal surgery. Group 1 will receive an intrathecal (IT) injection in the back in which a small dose duramorph and bupivacaine will be placed into the spinal fluid. Group 2 will receive an erector spinae plane (ESP) block in which bupivacaine and decadron are injected near the nerves under a muscle in the back.
Interventions
- DRUG IT Injection
- DRUG ESP Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2022-01-27 |
| Est. Completion | 2024-08-29 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05257941
The ClinicalTrials.gov registry entry for NCT05257941 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which IT Injection is the first listed.
NCT05257941 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05257941 about?
NCT05257941 is a clinical study titled "ESP Block VS Intrathecal Opioid After Laparoscopic Colorectal Surgery". This study is being done to compare 2 types of pain control methods and determine which is more effective postoperatively for laparoscopic colorectal surgery. Group 1 will receive an intrathecal (IT) injection in the back in which a small dose duramorph and bupivacaine will be placed into the spinal...
What is the current status of trial NCT05257941?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 116 participants. The study started on 2022-01-27. Estimated completion is 2024-08-29.
What interventions are being tested in trial NCT05257941?
The interventions under investigation include: IT Injection (DRUG), ESP Block (DRUG).
Who is sponsoring clinical trial NCT05257941?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.